Form 4: Amgen EVP Santos Reports Share Disposition

Amgen's EVP of Operations, Esteban Santos, reported a disposition of 5,621 common shares at $366.21 per share.

Summary

• Esteban Santos, Executive Vice President of Operations at Amgen Inc., reported a transaction on March 16, 2026.
• Santos disposed of 5,621 shares of Amgen common stock at a price of $366.21 per share.
• Following this transaction, Santos directly owns 82,404 shares, which include 696 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan.
• Santos also indirectly owns 909.9928 shares through the company's 401(k) Plan, representing interests in the Company's stock fund.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, representing a routine insider transaction without clear positive or negative implications for the company's operational or financial performance.

Negatives

• EVP of Operations Esteban Santos disposed of 5,621 common shares at $366.21 per share.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that insider transactions, such as this disposition by a key executive, are routinely monitored by investors for signals regarding management's confidence in the company's future. However, a single disposition, especially if for tax purposes or part of a pre-arranged plan (Rule 10b5-1), may not indicate a significant shift in sentiment.

Stakeholder Impact

• Shareholders: May observe executive share dispositions as a data point, but this single transaction is unlikely to have a material impact on overall shareholder value or sentiment without further context.

Key Dates

Recommendation

This Form 4 filing details a routine insider transaction by an executive, specifically a disposition of shares. Without additional context regarding the reason for the sale (e.g., tax withholding, pre-planned sale under Rule 10b5-1), it's difficult to interpret as a strong signal for the company's future performance. Therefore, a "hold" recommendation is appropriate as this filing alone does not provide sufficient information to alter an investment thesis.

Keywords

Amgen, AMGN, Esteban Santos, insider transaction, Form 4, stock disposition, executive compensation, 401k, common stock